![]() |
|
|
1 Chemical Therapeutics Research Laboratory, Miles Laboratories, Inc., Elkhart, Indiana
In a battery of tests, MA1337, a newly synthesized quinazolinedione derivative, was found to have central nervous system depressant activity at doses ranging from 0.06% to 1.9% of its acute LD50 in mice and rats. The dose-response curves of central depressant activity of MA1337 were flat. A blind cross-over behavioral observation in chronic dogs and cats for evaluation of central nervous system activity is described.
Accepted on January 6, 1965